Corporate ManufacturerCached Profile
FERRING PHARMACEUTICALS
Manufacturer Corporate ID: 100000000309
Subsidiaries Logged: 1 entities
LIFETIME CORPORATE SPEND
$2,838,380
General Payments Aggregated (2021–2025)
Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Top Funded Physicians
Physicians receiving the highest promotional payments from this corporation.
1. Dr. ANURAG MAHESHWARIMedical Doctor
$102,2962. Dr. FADY SHARARAMedical Doctor
$99,6743. Dr. GAUTAM JAYRAMMedical Doctor
$88,9344. Dr. RAVI CHAUHANMedical Doctor
$80,6395. Dr. PAUL FEUERSTADTMedical Doctor
$74,466Top Promoted Products
Drugs or medical devices receiving the highest marketing backing.
1. ADSTILADRIN$916,923 (32.3%)
2. MENOPUR$585,654 (20.6%)
3. REBYOTA$579,235 (20.4%)
4. CIMZIA$53,615 (1.9%)
5. INVOCELL$22,742 (0.8%)
Active Subsidiary Entities
Corporate subsidiaries and brands associated with this manufacturer ID in Open Payments.
FERRING PHARMACEUTICALS INC.
Corporate General Payouts Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2025
2025
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for FERRING PHARMACEUTICALS...